Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase III study of 5-fluorouracil versus 5-fluorouracil plus interferon alpha 2b versus 5-fluorouracil plus leucovorin in patients with advanced colorectal cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.
Kalofonos HP, Nicolaides C, Samantas E, Mylonakis N, Aravantinos G, Dimopoulos MA, Gennatas C, Kouvatseas G, Giannoulis E, Dervenis C, Basdanis G, Pavlidis N, Androulakis I, Fountzilas G; Hellenic Cooperative Oncology Group (HeCOG). Kalofonos HP, et al. Among authors: mylonakis n. Am J Clin Oncol. 2002 Feb;25(1):23-30. doi: 10.1097/00000421-200202000-00004. Am J Clin Oncol. 2002. PMID: 11823690 Clinical Trial.
Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Fountzilas G, Polichronis A, Katsohis K, Gennatas K, Toussis D, Skarlos D, Kosmidis P, Vassilaros S, Semoglou C, Giannakakis T, Fahantidis E, Klouvas G, Tsavaris N, Konstantaras C, Makrantonakis P, Kolotas C, Zamboglou N, Tsiliakos S, Hainoglou D, Mylonakis N, Pavlidis N. Fountzilas G, et al. Among authors: mylonakis n. Oncology. 1996 Mar-Apr;53(2):137-46. doi: 10.1159/000227550. Oncology. 1996. PMID: 8604240 Clinical Trial.
Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: a phase III randomized study. Preliminary results. Hellenic Cooperative Oncology Group.
Kosmidis P, Mylonakis N, Dimopoulos A, Pavlidis N, Fountzilas G, Samantas E, Dimitriadis K, Kalophonos C, Tsavdaridis D, Skarlos D. Kosmidis P, et al. Among authors: mylonakis n. Semin Oncol. 2000 Feb;27(1 Suppl 2):3-8. Semin Oncol. 2000. PMID: 10697029 Clinical Trial.
Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG).
Kosmidis P, Mylonakis N, Skarlos D, Samantas E, Dimopoulos M, Papadimitriou C, Kalophonos C, Pavlidis N, Nikolaidis C, Papaconstantinou C, Fountzilas G. Kosmidis P, et al. Among authors: mylonakis n. Ann Oncol. 2000 Jul;11(7):799-805. doi: 10.1023/a:1008389402580. Ann Oncol. 2000. PMID: 10997806 Free article. Clinical Trial.
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study.
Briasoulis E, Fountzilas G, Bamias A, Dimopoulos MA, Xiros N, Aravantinos G, Samantas E, Kalofonos H, Makatsoris T, Mylonakis N, Papakostas P, Skarlos D, Varthalitis I, Pavlidis N. Briasoulis E, et al. Among authors: mylonakis n. Cancer Chemother Pharmacol. 2008 Jul;62(2):277-84. doi: 10.1007/s00280-007-0604-7. Epub 2007 Sep 28. Cancer Chemother Pharmacol. 2008. PMID: 17901952 Clinical Trial.
Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study.
Skarlos DV, Samantas E, Kosmidis P, Fountzilas G, Angelidou M, Palamidas P, Mylonakis N, Provata A, Papadakis E, Klouvas G, et al. Skarlos DV, et al. Among authors: mylonakis n. Ann Oncol. 1994 Sep;5(7):601-7. doi: 10.1093/oxfordjournals.annonc.a058931. Ann Oncol. 1994. PMID: 7993835 Free article. Clinical Trial.
Carboplatin alone compared with its combination with epirubicin and cyclophosphamide in untreated advanced epithelial ovarian cancer: a Hellenic co-operative oncology group study.
Skarlos DV, Aravantinos G, Kosmidis P, Pavlidis N, Gennatas K, Beer M, Mylonakis N, Makrantonakis P, Klouvas G, Karpathios S, Linardou H, Konstantaras C, Fountzilas G. Skarlos DV, et al. Among authors: mylonakis n. Eur J Cancer. 1996 Mar;32A(3):421-8. doi: 10.1016/0959-8049(95)00537-4. Eur J Cancer. 1996. PMID: 8814685 Clinical Trial.
77 results